Preview

Pharma Sector Analysis India

Powerful Essays
Open Document
Open Document
2355 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Pharma Sector Analysis India
Indian Pharmaceutical Sector Analysis

Contents: * Introduction * Market Size & Growth Rates * Market Segmentation * Key Players in Pharma Industry * Market Drivers * Challenges for Pharma Industry * SWOT Analysis * References

Introduction
Indian Pharmaceutical Industry is one of the success stories of modern India. The wide ranging capabilities in the complex field of drug manufacture & technology has established India as one of the major producer of the Pharmaceuticals worldwide. De-licensing of the pharmaceutical industry gave freedom to Indian Pharma manufacturers to produce any drug without Industrial licensing. Technologically strong and totally self-reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific manpower, strength of national laboratories and an increasing balance of trade.
A highly organized sector, the Indian Pharma Industry is estimated to be worth $ 12 billion, growing at about 12-13 percent annually. The pharmaceutical industry in India meets around 70% of the country 's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectables. The industry is mostly based on allopathic medicines. There are about 250 large units and about 20000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These units produce the complete range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e., chemicals having therapeutic value and used for production of pharmaceutical formulations. The allopathic medicine industry consists of big players like Dr. Reddy’s, GSK, Pfizer, Ranbaxy and a lot of smaller players. The Pharmaceutical Industry, with its rich scientific talents and research capabilities, supported by Intellectual Property Protection regime is well set to take on



References: 1. http://HYPERLINK "http://www.ibef.org/industry/pharmaceuticals.aspx"wHYPERLINK "http://www.ibef.org/industry/pharmaceuticals.aspx"ww.ibef.org/industry/phHYPERLINK "http://www.ibef.org/industry/pharmaceuticals.aspx"aHYPERLINK "http://www.ibef.org/industry/pharmaceuticals.aspx"rmaHYPERLINK "http://www.ibef.org/industry/pharmaceuticals.aspx"cHYPERLINK "http://www.ibef.org/industry/pharmaceuticals.aspx"euticals.aspx 2. http://www.naukrihub.coHYPERLINK "http://www.naukrihub.com/india/pharmaceutical/overview/classification/"mHYPERLINK "http://www.naukrihub.com/india/pharmaceutical/overview/classification/"/india/pharmHYPERLINK "http://www.naukrihub.com/india/pharmaceutical/overview/classification/"aHYPERLINK "http://www.naukrihub.com/india/pharmaceutical/overview/classification/"ceutHYPERLINK "http://www.naukrihub.com/india/pharmaceutical/overview/classification/"iHYPERLINK "http://www.naukrihub.com/india/pharmaceutical/overview/classification/"cal/overview/classification/ 3. http://buHYPERLINK "http://business.mapsofindia.com/pharmaceutical/"sHYPERLINK "http://business.mapsofindia.com/pharmaceutical/"iness.mapsofHYPERLINK "http://business.mapsofindia.com/pharmaceutical/"iHYPERLINK "http://business.mapsofindia.com/pharmaceutical/"ndia.cHYPERLINK "http://business.mapsofindia.com/pharmaceutical/"oHYPERLINK "http://business.mapsofindia.com/pharmaceutical/"m/pHYPERLINK "http://business.mapsofindia.com/pharmaceutical/"hHYPERLINK "http://business.mapsofindia.com/pharmaceutical/"armaceutical/ 4. www.HYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"businessHYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"-HYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"sHYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"tandardHYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/".HYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"cHYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"oHYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"m/.../HYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"ciplaHYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"...HYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"topHYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"...HYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/"pharmaHYPERLINK "http://www.business-standard.com/.../cipla...top...pharma.../385124/".../385124/ 5. http://www.tHYPERLINK "http://www.theindusview.com/vol4Issue5/specialreport.html"hHYPERLINK "http://www.theindusview.com/vol4Issue5/specialreport.html"eindusview.com/vol4IHYPERLINK "http://www.theindusview.com/vol4Issue5/specialreport.html"sHYPERLINK "http://www.theindusview.com/vol4Issue5/specialreport.html"sue5/specialreport.html 6. http://www.HYPERLINK "http://www.equitymaster.com/research-it/sector-info/pharma/"eHYPERLINK "http://www.equitymaster.com/research-it/sector-info/pharma/"quHYPERLINK "http://www.equitymaster.com/research-it/sector-info/pharma/"iHYPERLINK "http://www.equitymaster.com/research-it/sector-info/pharma/"tHYPERLINK "http://www.equitymaster.com/research-it/sector-info/pharma/"yHYPERLINK "http://www.equitymaster.com/research-it/sector-info/pharma/"master.HYPERLINK "http://www.equitymaster.com/research-it/sector-info/pharma/"cHYPERLINK "http://www.equitymaster.com/research-it/sector-info/pharma/"om/research-it/sector-info/pharma/ 7. http://www.naukrihub.com/india/pharmaceutical/overview/swot-analysis/

You May Also Find These Documents Helpful

  • Powerful Essays

    Ego Executive Report

    • 3226 Words
    • 13 Pages

    Greene, W. (2007), “The emergence of India’s pharmaceutical industry and implications for the US Generic Drug Market”, US International Trade Commission.…

    • 3226 Words
    • 13 Pages
    Powerful Essays
  • Powerful Essays

    Currently the industry is highly regulated; however trends seem to be changing. Factors contributing to this change are the sheer size and growth of Indian domestic pharmaceutical industry, which as a result makes it increasingly difficult for the government to regulate every firms. Secondly pressure being applied from World trade Organisation to speed up discussions within the national government to improve patent protection. This will result in providing foreign pharmaceutical firms being provided improved marketing opportunities in the Indian Enormous Drug market over years to come. Blackmores however would like to get a head start and move in to get a strong foothold in this industry by marketing the Cold/Flu Night And Day…

    • 4700 Words
    • 19 Pages
    Powerful Essays
  • Good Essays

    Retail Pharmacies

    • 4248 Words
    • 17 Pages

    The pharmacy trade in the country generates an estimated business of Rs. 32,000 crore, apart from about Rs. 18,000 added by hospital pharmacies and exports. Almost all the chemists beside selling allopathic medicines also offer OTC and alternate medicines, surgicals, rehabilitation aids and bodycare products like soaps, tooth pastes, hair oils, shampoos, cleansing lotions and neutraceuticals, among others, for sale which according to rough estimates generate an additional turnover of about Rs. 15,000 crore.…

    • 4248 Words
    • 17 Pages
    Good Essays
  • Good Essays

    There are number of factors that have contributed towards this phenomenal growth in the drug industry. The initial event that initiated the growth was India’s agreement with WTO which gave protection to intellectual property rights and assurance to international investors. Also, there are several internal factors within India which have successfully contributed to the growth of the industry. Similar to China, India has comparative advantage in manufacturing and packaging which encouraged Western companies to outsource in India. The comparative advantage has been gained due to abundance of educated work force, low wage rates and the wide spread use of English as a business language. This latter factor, the wide use of English language is one of the main reasons why Western companies chose India over China. For foreign investors, it is much easier to conduct business…

    • 860 Words
    • 4 Pages
    Good Essays
  • Satisfactory Essays

    Eli Lily Case Study

    • 489 Words
    • 2 Pages

    It was a right strategy for Eli Lilly that started a joint venture with Ranbaxy to enter the Indian market. First of all, Ranbaxy was the second largest pharmaceutical company that manufactures bulk drugs and generic drugs in India, with a domestic market share of 15 per cent. It had established broad distribution network, and it was the second largest exporter of all products in India. Ranbaxy’s capital costs were 50 per cent to 75 per cent lower than those of comparable U.S. plants. Second, the timing was perfect for Eli Lilly to enter the Indian market. During 1970s, the Patents Act 1970 and the Drug Price Control Order (DPCO) was issued. And India was opening its drug market. Third, there was possibility to conduct cheap clinical trials in India.…

    • 489 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Pfizer, US pharmaceutical company is one of the largest pharmaceutical companies in the world. Unfortunately, Pfizer faced challenges by macro-environment forces that affect their sales volume decline dramatically in 2011. PESTEL, Porter’s Five Forces and Industry Lift Cycle frameworks to be applied to analysis the broad macro-environment that affected Pfizer in the pharmaceutical industry.…

    • 1782 Words
    • 8 Pages
    Good Essays
  • Good Essays

    THE pharmaceutical market in India today is worth Rs.57206 crores up from Rs. 5000 crores in 1995*. It is one of the fastest growing markets with a growth rate of around 15%. India has a large number of Pharmaceutical companies which operate in an environment of high competition. The competition is even higher in a high generic market like in India where drugs are in fierce price competition. It is estimated that there are around 20,000 pharmaceutical companies* in India, competing for a share of the market, in a poorly regulated environment. To be ahead in the race, pharmaceutical companies are investing highly in marketing and promotion of their drugs. The Consumer International Report 2010, on an average, the Indian Pharmaceutical companies spend almost 30% of their revenue in drug promotion which is one of the highest percentage in the world.…

    • 873 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    The Indian Pharmaceutical Industry is among top five producers of bulk drugs in the world. Pharmaceuticals market can be roughly classified into Bulk drugs (20% of the market) registering growth rates of 20% and formulations (80% of the market) with an annual growth rate of 15%.There are about 8174 bulk drug manufacturing units and 2389 formulations units spread across the country.…

    • 11559 Words
    • 47 Pages
    Powerful Essays
  • Powerful Essays

    This report presents the cases of the top five global pharma companies: J&J, Pfizer, GSK, Novartis…

    • 1109 Words
    • 5 Pages
    Powerful Essays
  • Good Essays

    Pharmacy Sop

    • 1074 Words
    • 5 Pages

    The last decade has been an absolutely exciting time in the journey of the Indian Pharmaceutical Industry. With the signing of the General Agreement of Trade and Tariff and the World Trade Organization Treaty, India agreed to recognize both product and process patents. This made patented drugs with a modified process. Due to this, India has developed tremendous competitive edge in the manufacturing bulk drugs and formulations. These abundant opportunities with their challenges are where I see myself making a contribution to the Indian Pharmaceutical Industry and in turn the world at large. How and why require just brief journey into my past.…

    • 1074 Words
    • 5 Pages
    Good Essays
  • Best Essays

    The aim of the study is to analyze the changes that took place in Bangladesh Pharmaceutical Industries Channel system in the past decade. The current scenario of the pharmaceutical Industry in Bangladesh and external effects that might bring in further changes in the industry is to be thoroughly looked at. Countries with similar channel structure are also analyzed in this course of study. Countries such as Japan, India and Myanmar are presented with their issues and successes. The Rapid growth of the Bangladesh pharmaceutical industry gave birth to many scopes in creation of different forms of Channel Intermediaries such as wholesalers, retailers out sourced salesperson, and manufacturer sales reps. The pharmaceutical industry developed rapidly from the 1980s after the introduction of Drug (Control) Ordinance-1982. Adequate infrastructure and use of trained manpower were two essential requisites for implementation of national pharmaceutical policies in Bangladesh. The country was importing significant amount of medicine and also raw materials for the industry from abroad. But the industry has started to export its products in foreign market, especially in the Middle East and Europe with great success. This study tries to identify the similarities and dissimilarities between the Bangladeshi pharmaceutical Industry and the Pharmaceutical Industries in neighboring countries where the industry infrastructure not too far from Bangladesh’s.…

    • 3271 Words
    • 14 Pages
    Best Essays
  • Powerful Essays

    The annual turnover of three of the major Indian systems of medicine namely Ayurveda, Unani and Sidha is estimated to be more than a billion dollar. The gap between demand and supply is estimated to be 200,000 tons, which is expected to rise to 400,000. Today, one fourth of the world population depends on traditional medicines. The reason behind the enormous growth in demand for Medicinal plants is due to their lesser side effects as compared to the allopathic preparations and the cost factor.…

    • 2660 Words
    • 11 Pages
    Powerful Essays
  • Powerful Essays

    4th & 5th Floors, Astral Heights, Road No. 1, Banjara Hills, Hyderabad-500034, India Tel: +91-40-23430203-07, Fax: +91-40-23430208, E-mail: info@cygnusindia.com Website: www.cygnusindia.com…

    • 1390 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    The industry is legally permitted to reverse engineer, manufacture and sell generic versions of on-patent pharmaceutical products for domestic consumption as well as for export to other least Developed Countries (LDCs). It created a big opportunity to make Bangladesh a new chemical entity. Bangladesh can share its long years of experience in pharmaceutical formulation and marketing with the LDCs and developing ones, who need it. Among the 50 LDCs, Bangladesh has the strongest base to manufacture pharmaceutical products. Over $300 million invested in the sector, has helped modernise and create new facilities.…

    • 2766 Words
    • 17 Pages
    Powerful Essays
  • Good Essays

    The size of the pharmaceutical market in Pakistan is Rs.101 Billion (USD 1.2 Billion) and it is growing at a rate of about 12 - 15% per annum. There are presently 448 manufacturing units in Pakistan and there are 28 multinational companies operating in the country which have a 50% market share, suggesting that the market is quality-sensitive. Export of pharmaceuticals is limited, presently worth only USD 100 million, and these are destined mainly for African, Central Asian and South-East Asian countries. European, Australian and American markets remain beyond the industry’s reach owing to lack of the requisite manufacturing standards. Amongst the manufactured exports, pharmaceuticals rank seventh but more impressive is their growth which is twice the overall export growth of Pakistan.…

    • 993 Words
    • 4 Pages
    Good Essays